Phase 3 Trial Evaluating Both Erlotinib And Chemoradiation As Adjuvant Treatment For Patients With Resected Head Of Pancreas Adenocarcinoma
Brief description of study
If you have been diagnosed with pancreatic cancer and have undergone surgery for your cancer, you may qualify for a clinical trial evaluating adjuvant treatment (therapy administered in addition to surgery). Purpose The goal of the study is to determine whether the addition of radiation to adjuvant chemotherapy improves patient Outcomes as compared to chemotherapy alone in patients following complete removal of their pancreas cancer.
Clinical Study Identifier: 11-00773
ClinicalTrials.gov Identifier: NCT11-00773
If you are registered as a volunteer, please log in to contact the study team/express interest in this study.
